Synthesis of fluorinated carbocyclic pyrimidine nucleoside analogues. 2022

Caecilie M M Benckendorff, and Valentyna D Slyusarchuk, and Ningwu Huang, and Marcelo A Lima, and Mark Smith, and Gavin J Miller
Centre for Glycosciences, Keele University, Keele, Staffordshire, ST5 5BG, UK. g.j.miller@keele.ac.uk.

Analogues of the canonical nucleosides have a longstanding presence and proven capability within medicinal chemistry and drug discovery research. The synthesis reported herein successfully replaces furanose oxygen with CF2 and CHF in pyrimidine nucleosides, granting access to an alternative pharmacophore space. Key diastereoselective conjugate addition and fluorination methodologies are developed from chiral pool materials, establishing a robust gram-scale synthesis of 6'-(R)-monofluoro- and 6'-gem-difluorouridines. Vital intermediate stereochemistries are confirmed using X-ray crystallography and NMR analysis, providing an indicative conformational preference for these fluorinated carbanucleosides. Utilising these 6'-fluorocarbauridine scaffolds enables synthesis of related cytidine, ProTide and 2'-deoxy analogues alongside a preliminary exploration of their biological capabilities in cancer cell viability assays. This synthetic blueprint offers potential to explore fluorocarbanucleoside scaffolds, indicatively towards triphosphate analogues and as building blocks for oligonucleotide synthesis.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal

Related Publications

Caecilie M M Benckendorff, and Valentyna D Slyusarchuk, and Ningwu Huang, and Marcelo A Lima, and Mark Smith, and Gavin J Miller
January 1991, Yao xue xue bao = Acta pharmaceutica Sinica,
Caecilie M M Benckendorff, and Valentyna D Slyusarchuk, and Ningwu Huang, and Marcelo A Lima, and Mark Smith, and Gavin J Miller
January 2018, Anti-cancer agents in medicinal chemistry,
Caecilie M M Benckendorff, and Valentyna D Slyusarchuk, and Ningwu Huang, and Marcelo A Lima, and Mark Smith, and Gavin J Miller
January 1991, Journal of medicinal chemistry,
Caecilie M M Benckendorff, and Valentyna D Slyusarchuk, and Ningwu Huang, and Marcelo A Lima, and Mark Smith, and Gavin J Miller
January 2014, Beilstein journal of organic chemistry,
Caecilie M M Benckendorff, and Valentyna D Slyusarchuk, and Ningwu Huang, and Marcelo A Lima, and Mark Smith, and Gavin J Miller
September 1981, Journal of medicinal chemistry,
Caecilie M M Benckendorff, and Valentyna D Slyusarchuk, and Ningwu Huang, and Marcelo A Lima, and Mark Smith, and Gavin J Miller
September 2019, Molecules (Basel, Switzerland),
Caecilie M M Benckendorff, and Valentyna D Slyusarchuk, and Ningwu Huang, and Marcelo A Lima, and Mark Smith, and Gavin J Miller
January 2018, Nucleosides, nucleotides & nucleic acids,
Caecilie M M Benckendorff, and Valentyna D Slyusarchuk, and Ningwu Huang, and Marcelo A Lima, and Mark Smith, and Gavin J Miller
October 2004, Chemistry (Weinheim an der Bergstrasse, Germany),
Caecilie M M Benckendorff, and Valentyna D Slyusarchuk, and Ningwu Huang, and Marcelo A Lima, and Mark Smith, and Gavin J Miller
November 2016, The Journal of organic chemistry,
Caecilie M M Benckendorff, and Valentyna D Slyusarchuk, and Ningwu Huang, and Marcelo A Lima, and Mark Smith, and Gavin J Miller
July 2020, Organic letters,
Copied contents to your clipboard!